[HTML][HTML] The effectiveness of Paxlovid treatment in long-term care facilities in South Korea during the outbreak of the Omicron variant of SARS-CoV-2

H Park, YJ Park, HY Lee, M Yu, YJ Song… - Osong Public Health …, 2022 - ncbi.nlm.nih.gov
Objectives On November 5, 2021, Pfizer Inc. announced Paxlovid (nirmatrelvir+ ritonavir) as
a treatment method that could reduce the risk of hospitalization or death for patients with …

[HTML][HTML] Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to …

RK Kim, YJ Choe, EJ Jang, C Chae… - Journal of Korean …, 2023 - ncbi.nlm.nih.gov
Background This retrospective observational matched-cohort study of 2,151,216 individuals
from the Korean coronavirus disease 2019 (COVID-19) vaccine effectiveness cohort aimed …

Risk of SARS-CoV-2 breakthrough infection following NVX-CoV2373 and BNT162b2 vaccinations in Korean Adults: A population-based observational study

HK Kim, SK Park, SA Choe, ES Gwak, BJ Cowling… - Vaccine, 2024 - Elsevier
South Korea experienced a low prevalence of SARS-CoV-2 until the emergence of the
omicron in early 2022, triggering a major community epidemic. To evaluate effectiveness of …

[HTML][HTML] Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA. 1 in Older Individuals

JS Park, J Jeon, J Um, YY Choi, MK Kim… - Infection & …, 2024 - ncbi.nlm.nih.gov
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant (B. 1.1. 529) is dominating coronavirus disease 2019 (COVID-19) worldwide. The …

Republic of Korea

HJ Lee - The Palgrave handbook of global perspectives on …, 2019 - Springer
Abstract The culture of South Korea is rooted in Confucianism but recent decades have
brought modifications reflective of international influences, changes in popular culture, the …

[HTML][HTML] Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection by Type and Frequency of Vaccine: A Community-Based Case …

H Gim, H Seo, BC Chun - Journal of Korean Medical Science, 2024 - ncbi.nlm.nih.gov
Background Although guidelines recommend vaccination for individuals who have
recovered from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[HTML][HTML] Correlation Between Third Dose of COVID-19 Vaccines and Regional Case Fatality Rates During the Omicron Wave in Korea

Y Jang, IJ Kim, SS Moon, SB Kim… - Journal of Korean …, 2022 - synapse.koreamed.org
This study seeks to find the correlation between case fatality rates (CFRs) and third-dose
vaccination coverage in 244 counties (si/gun/gu) of South Korea during the omicron variant …

[HTML][HTML] Presumed population immunity to SARS-CoV-2 in South Korea, April 2022

EJ Jang, YJ Choe, SA Choe, YY Kim… - Osong public health …, 2022 - ncbi.nlm.nih.gov
Objectives We estimated the overall and age-specific percentages of the Korean population
with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARS …

[HTML][HTML] mRNA vaccine effectiveness against SARS-CoV-2 B. 1.617. 2 (Delta) and B. 1.1. 529 (Omicron) variant transmission from home care cases to household …

H Park, YJ Park, SE Lee, MJ Lee… - Osong Public Health and …, 2022 - ncbi.nlm.nih.gov
Objectives Household contacts of confirmed cases of coronavirus disease 2019 (COVID-19)
are exposed to a high risk of viral transmission, and secondary incidence is an important …

Comparative Effectiveness of BNT162b2 and NVX-CoV2373 Vaccines in Korean Adults

SK Park, YJ Choe, SA Choe, BJ Cowling, JH Hwang… - medRxiv, 2023 - medrxiv.org
Background Various types of vaccines against SARS-CoV-2 have reduced the burden of
coronavirus diseases 2019 (COVID-19) across the world. We conducted an observational …